Biotechnology News

February 21, 2013

NEW YORK--(BUSINESS WIRE)--Medikly today announced the close of a $1.2M Series A round of funding led by Easton Capital Investment Group.

February 21, 2013

DUBLIN--(BUSINESS WIRE)--ICON plc Announces Appointment of Professor William Hall to Board of Directors

February 21, 2013

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Kinetigen, Inc. exhibiting at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Annual Meeting

February 21, 2013

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--More than two-thirds of medical science liaison (MSL) team budgets is dedicated to direct salaries and overhead or travel expenses, a recent study from Cutting Edge Information found.

February 21, 2013

ST. PAUL, Minn.--(BUSINESS WIRE)--A program at Regions Hospital to remove patients from a ventilator within six hours after heart surgery improves recovery time and lowers medical costs.

February 21, 2013

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization (BIO) announced its plenary session program for the 2013 World Congress on Industrial Biotechnology featuring biofuel and biobased product company executives, scientists and...

February 21, 2013

SAN ANTONIO--(BUSINESS WIRE)--Health systems today are under more pressure than ever to improve clinical and business outcomes and increase market share, often through physician group and facility acquisitions. But, integrating and delivering...

February 21, 2013

DENVER--(BUSINESS WIRE)--MPEG LA today announced that the Wisconsin Alumni Research Foundation (WARF) has become a participating patent holder in Librassay®, MPEG LA’s licensing supermarket of diagnostic and research tool patent rights for tests...

February 21, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--SynapDx Corporation’s CEO Stanley Lapidus discusses diagnostic issues at inaugural Autism Investment Conference hosted by Autism Speaks

February 21, 2013

LEXINGTON, Mass.--(BUSINESS WIRE)--LabCorp invests $2 million in SynapDx Corporation

February 21, 2013

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for instrument containers

February 21, 2013

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Allenex AB (STO:ALNX): For the fourth quarter October - December · Net sales for the quarter amounted to SEK 27.4 million (27.5). Sales were impacted by a negative currency effect of SEK 1.2 million...

February 21, 2013

SAN ANTONIO--(BUSINESS WIRE)--GenSpera treats first patient in G-202 Phase II hepatocellular cancer trial.

February 21, 2013

ERLANGEN, Germany--(BUSINESS WIRE)--Cerbomed opens up new markets: From March on t-VNS with NEMOS will be available in Italy for the treatment of epilepsies.

February 21, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--N-of-One announced a partnership with Fox Chase Cancer Center to provide molecular interpretation and treatment strategy analysis for genome sequencing and testing provided to advanced cancer patients

February 21, 2013

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed, ISIS Pharma and CHDI collaboration advances Huntington’s disease therapy development with state-of-the-art biomarker technology

February 21, 2013

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced top-line results for a Phase 3 study that showed Lyrica® (pregabalin) Capsules CV were as effective as levetiracetam as an adjunctive therapy in adult epilepsy patients...

February 21, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Living Proof raises $30 million and launches first national marketing campaign with Jennifer Aniston

February 21, 2013

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals reports record revenues, profits, and cash generated from operations for the 12-month period ended December 31, 2012.

February 21, 2013

NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of cloud-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the fourth quarter...

February 21, 2013

MEMPHIS, Tenn.--(BUSINESS WIRE)--GTx, Inc. (Nasdaq: GTXI) today provided a Company update and reported financial results for the fourth quarter and full year 2012. “We have completed enrollment of our two pivotal Phase III clinical trials...

February 21, 2013

LONDON--(BUSINESS WIRE)--Market research report “Prostvac (Prostate Cancer) - Forecast and Market Analysis to 2022” elaborated by GlobalData has been recently published at MarketPublishers.com

February 21, 2013

YAVNE, Israel--(BUSINESS WIRE)--Avraham Pharmaceuticals Ltd. announced today that Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, Pontifax, Clal Biotechnology Industries (TASE:CBI) and...

February 21, 2013

DÜSSELDORF, Germany--(BUSINESS WIRE)--Ventac Partners begleitet MBO von miacom diagnostics

February 21, 2013

LEATHERHEAD, England--(BUSINESS WIRE)--In its 6th year, EFIB is clearly established as the market leading conference for this sector and 2013 marks its transformation from a large conference to a full scale congress. Taking place at the SQUARE,...

February 21, 2013

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: ContextVision AB: (OSE:COV) Q4 2012 HIGHLIGHTS · Significant sales development · Europe strengthened position · 3D Ultrasound focus at RSNA in Chicago · Product upgrades for Ultrasound, XR, MRI and iRV...

February 21, 2013

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Fingerprint Cards AB (publ)(STO:FINGB), Corp. Reg. No. 556154-2381, (FPC), Fourth quarter 2012: · Sales totaled SEK 1.9 M (18.6). · According to the new calculation method, a gross loss of SEK 1.5 M (...

February 21, 2013

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573): Sucampo Pharmaceuticals, Inc. (hereinafter referred to as "Sucampo") announced that RESCULA® Eye Drops had been launched in the U.S. market. (See Sucampo's press release dated February 19, 2013...

February 21, 2013

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US, Non-UK & Non-Canadian Media Only Today, the New England Journal of Medicine published findings from the RE-MEDYTM and RE-SONATETM trials investigating Pradaxa® (dabigatran etexilate) in the...

February 21, 2013

CAMBRIDGE, Mass. & LAUSANNE, Switzerland--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced the appointment of Jonathan E. Dickinson to the position of General Manager, ARIAD Pharmaceuticals (Europe), Sàrl. Mr....

February 21, 2013

HERZLIYA-PITUACH, Israel & TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: Immune Pharmaceuticals Ltd. (“Immune”), a privately held Israeli company, and EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today...

February 20, 2013

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) announced today that it will present at the 2013 RBC Capital Markets Global Healthcare Conference. The webcast will be live on Tuesday, February 26, 2013 at 9:30 a.m. ET. To access...

February 20, 2013

MOSCOW--(BUSINESS WIRE)--The investment committee of RVC Biofund has approved the investment in Andrus Reo, a recently established startup which will conduct phase III clinical trials for an antineoplastic drug in Russia.

February 20, 2013

JACKSONVILLE, Fla.--(BUSINESS WIRE)--The American Association of Clinical Endocrinologists (AACE) today issued a consensus statement outlining recommended clinical approaches to the detection of lipodystrophy (LD), a seemingly rare condition...

February 20, 2013

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Relypsa, Inc. a clinical-stage biopharmaceutical company, announced that the first patient has been enrolled in the company’s pivotal Phase 3 clinical study.

February 20, 2013

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen announces settlement terms reached for Tenor litigation.

February 20, 2013

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced the SureSelect Strand-Specific RNA Library Preparation Kit for whole transcriptome and targeted RNA sequencing. The new kit enables researchers to prepare...

February 20, 2013

PHILADELPHIA--(BUSINESS WIRE)--Integral Molecular was issued a patent covering its Lipoparticle technology for cell-free detection of ion channel function. The technology enables HTS screening against ion channel targets.

February 20, 2013

NEWTON, Mass. and PRINCETON, N.J.--(BUSINESS WIRE)--Mathematica Policy Research, a pioneer in social policy research, has selected New England Institutional Review Board (NEIRB) as their IRB of record for review of Mathematica’s SBER research...

February 20, 2013

CARY, N.C.--(BUSINESS WIRE)--Growth/decline of Late Phase study conduct and outsourcing, a 3-year quantitative benchmark of Late Phase studies, the use of Late Phase service providers, and Pharma's decision-making structure.

February 20, 2013

WALTHAM, Mass.--(BUSINESS WIRE)--The Massachusetts eHealth Collaborative (MAeHC), a non-profit pioneer and leader in healthcare delivery through health information technology, announced today that it has been selected by the New Hampshire Health...

February 20, 2013

SANTA MONICA, Calif.--(BUSINESS WIRE)--Orion Health, the leader in eHealth technology, today announced that Memorial Sloan-Kettering has chosen Orion Health’s Rhapsody Integration Engine to replace its current healthcare integration engine and...

February 20, 2013

MANILA, Philippines--(BUSINESS WIRE)--For the first time since the introduction of biotech/GM crops almost two decades ago, developing countries have grown more hectares of biotech crops than industrialized countries, contributing to food...

February 20, 2013

SAN CARLOS, Calif.--(BUSINESS WIRE)--NuGEN announces the launch of the new Mondrian SP+ System and associated reagent methods to support a fully automated workflow for a range of NGS applications.

February 20, 2013

LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology and the FDA Agree on an SPA for the Phase III trial of PB272 (neratinib) in HER2-positive metastatic breast cancer patients who have failed two or more prior treatments.

February 20, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that Martin D. Williams, president and chief executive officer, is scheduled to...

February 20, 2013

SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ: CELG) announced today that it has entered into an accelerated share repurchase (ASR) agreement with an investment bank to repurchase an aggregate of $600 million of the company’s common...